BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26079428)

  • 1. PTPRD silencing by DNA hypermethylation decreases insulin receptor signaling and leads to type 2 diabetes.
    Chen YT; Lin WD; Liao WL; Lin YJ; Chang JG; Tsai FJ
    Oncotarget; 2015 May; 6(15):12997-3005. PubMed ID: 26079428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes.
    Chen YT; Liao JW; Tsai YC; Tsai FJ
    Oncotarget; 2016 Jun; 7(26):39162-39170. PubMed ID: 27322146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT5C2 methylation regulatory interplay between DNMT1 and insulin receptor in type 2 diabetes.
    Chen YT; Lin WD; Liao WL; Tsai YC; Liao JW; Tsai FJ
    Sci Rep; 2020 Sep; 10(1):16087. PubMed ID: 32999320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered
    Parrillo L; Spinelli R; Longo M; Desiderio A; Mirra P; Nigro C; Fiory F; Hedjazifar S; Mutarelli M; Carissimo A; Formisano P; Miele C; Smith U; Raciti GA; Beguinot F
    Epigenomics; 2020 May; 12(10):873-888. PubMed ID: 32483983
    [No Abstract]   [Full Text] [Related]  

  • 5. Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort.
    Chang YC; Chiu YF; Liu PH; Shih KC; Lin MW; Sheu WH; Quertermous T; Curb JD; Hsiung CA; Lee WJ; Lee PC; Chen YT; Chuang LM
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):365-72. PubMed ID: 21767287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia.
    Song L; Jiang W; Liu W; Ji JH; Shi TF; Zhang J; Xia CQ
    Acta Paediatr; 2016 Mar; 105(3):e132-41. PubMed ID: 26607758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
    Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
    Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers.
    Veeriah S; Brennan C; Meng S; Singh B; Fagin JA; Solit DB; Paty PB; Rohle D; Vivanco I; Chmielecki J; Pao W; Ladanyi M; Gerald WL; Liau L; Cloughesy TC; Mischel PS; Sander C; Taylor B; Schultz N; Major J; Heguy A; Fang F; Mellinghoff IK; Chan TA
    Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9435-40. PubMed ID: 19478061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in PTPRD and risk of gestational diabetes mellitus.
    Chen T; Xu J; Liu G; Liu H; Chen M; Qin Y; Wu W; Xia Y; Ji C; Guo X; Wen J; Wang X
    Oncotarget; 2016 Nov; 7(46):76101-76107. PubMed ID: 27738328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of PTPRD correlates with poor prognosis in gastric adenocarcinoma.
    Wang D; Wang L; Zhou J; Pan J; Qian W; Fu J; Zhang G; Zhu Y; Liu C; Wang C; Jin Z; He Z; Wu J; Shi B
    PLoS One; 2014; 9(11):e113754. PubMed ID: 25412184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.
    Pei Q; Huang Q; Yang GP; Zhao YC; Yin JY; Song M; Zheng Y; Mo ZH; Zhou HH; Liu ZQ
    Acta Pharmacol Sin; 2013 Feb; 34(2):255-61. PubMed ID: 23147557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer.
    Peyser ND; Du Y; Li H; Lui V; Xiao X; Chan TA; Grandis JR
    PLoS One; 2015; 10(8):e0135750. PubMed ID: 26267899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.
    Xu J; Zhong Y; Yin H; Linneman J; Luo Y; Xia S; Xia Q; Yang L; Huang X; Kang K; Wang J; Niu Y; Li L; Gou D
    J Hypertens; 2022 Sep; 40(9):1795-1807. PubMed ID: 35848503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin.
    Bae WJ; Ahn JM; Byeon HE; Kim S; Lee D
    J Exp Clin Cancer Res; 2019 Dec; 38(1):484. PubMed ID: 31805999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
    Acun T; Demir K; Oztas E; Arango D; Yakicier MC
    OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes.
    Yang BT; Dayeh TA; Volkov PA; Kirkpatrick CL; Malmgren S; Jing X; Renström E; Wollheim CB; Nitert MD; Ling C
    Mol Endocrinol; 2012 Jul; 26(7):1203-12. PubMed ID: 22570331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dnmt1 overexpression causes genomic hypermethylation, loss of imprinting, and embryonic lethality.
    Biniszkiewicz D; Gribnau J; Ramsahoye B; Gaudet F; Eggan K; Humpherys D; Mastrangelo MA; Jun Z; Walter J; Jaenisch R
    Mol Cell Biol; 2002 Apr; 22(7):2124-35. PubMed ID: 11884600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long noncoding RNA Ptprd-IR is a novel molecular target for TGF-β1-mediated nephritis.
    Pu Y; Zhao H; Wu X; Mei M; Shen B
    Int J Biochem Cell Biol; 2020 May; 122():105742. PubMed ID: 32173520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
    Ortiz B; Fabius AW; Wu WH; Pedraza A; Brennan CW; Schultz N; Pitter KL; Bromberg JF; Huse JT; Holland EC; Chan TA
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8149-54. PubMed ID: 24843164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.